- Reports Full-Year Diluted EPS of $3.30 on a GAAP Basis; Adjusted Diluted EPS of $5.60 Reflects Growth of 16.2 Percent - Delivers Full-Year Net Revenues of $28.216 Billion; Adjusted Net Revenues Increased 10.1 Percent on an Operational Basis - Full-Year Global HUMIRA Sales of $18.427 Billion

NORTH CHICAGO, Ill. , Jan. 12, 2018 /PRNewswire/ --  AbbVie (NYSE: ABBV) will announce its fourth-quarter 2017 financial results on Friday, Jan. 26, 2018 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time ( 9 a.m. Eastern).

NORTH CHICAGO, Ill. , Dec. 20, 2017 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the 36th Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2018 . Richard A. Gonzalez , chairman and chief executive officer, will present at 10:30 a.m. Central time .

NORTH CHICAGO, Ill. , Dec. 19, 2017 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Goldman Sachs 10th Annual Healthcare CEOs Unscripted: A View from the Top on Thursday, January 4, 2018 . Richard A. Gonzalez, chairman and chief executive officer, will present at 10 a.m. Central time .

NORTH CHICAGO, Ill. , Nov. 15, 2017 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the Evercore ISI Biopharma Catalyst/Deep Dive Conference on Wednesday, November 29, 2017 . Bill Chase , executive vice president and chief financial officer, will present at 7 a.m. Central time .

NORTH CHICAGO, Ill. , Nov. 3, 2017 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Jefferies 2017 London Healthcare Conference on Thursday, Nov. 16, 2017 . Bill Chase , executive vice president and chief financial officer, will present at 3:20 a.m. Central time .

- Reports Third-Quarter Diluted EPS of $1.01 on a GAAP Basis; Adjusted Diluted EPS of $1.41, Reflecting Growth of 16.5 Percent - Delivers Third-Quarter Net Revenues of $6.995 Billion; Adjusted Net Revenues Increased 8.8 Percent on an Operational Basis - Third-Quarter Global HUMIRA Sales of $4.701

NORTH CHICAGO, Ill. , Oct. 27, 2017 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) increased the company's quarterly cash dividend by 11 percent from $0.64 per share to $0.71 per share.  The cash dividend is payable February 15, 2018 to shareholders of record at the close of

NORTH CHICAGO, Ill. , Oct. 18, 2017 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the 2017 Credit Suisse Health Care Conference on Wednesday, November 8, 2017 . Bill Chase , executive vice president and chief financial officer, will present at 12 p.m. Central time .

NORTH CHICAGO, Ill. , Oct. 9, 2017 /PRNewswire/ --  AbbVie (NYSE: ABBV) will announce its third-quarter 2017 financial results on Friday, Oct. 27, 2017 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time ( 9 am Eastern).